JP-listed companies
OncoTherapy Science, Inc.

OncoTherapy Science, Inc.JP:4564

Market cap

¥9.6B

P/E ratio

Income statement Balance sheet Cash flow

	Mar 31, 2012	Mar 31, 2013	Mar 31, 2014	Mar 31, 2015	Mar 31, 2016	Mar 31, 2017	Mar 31, 2018	Mar 31, 2019	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024
Cash and deposits	-	8,497	17,825	16,072	13,070	10,073	6,740	4,858	4,714	2,899	1,837	1,118	528
Accounts receivable - trade	-	1,357	34	12	-	2	0	17	29	152	400	123	36
Raw materials and supplies	-	26	26	22	16	13	15	25	18	31	123	52	44
Work in process	-	-	-	-	-	-	-	-	7	11	108	47	30
Advance payments to suppliers	-	765	63	39	65	79	83	11	3	14	19	16	9
Raw materials and supplies	-	26	26	22	16	13	15	25	18	31	123	52	44
Advance payments to suppliers	-	765	63	39	65	79	83	11	3	14	19	16	9
Prepaid expenses	-	-	-	-	-	-	-	-	-	-	-	7	5
Income taxes refund receivable	-	253	-	-	-	-	-	-	-	-	-	-	67
Short-term loans receivable from subsidiaries and associates	-	-	-	-	-	-	-	-	-	-	-	100	-
Consumption taxes refund receivable	-	-	-	-	-	-	-	-	-	-	-	51	87
Income taxes refund receivable	-	253	-	-	-	-	-	-	-	-	-	-	67
Other	-	167	193	92	137	122	195	144	107	88	114	66	18
Consumption taxes refund receivable	-	-	-	-	-	-	-	-	-	-	-	51	87
Current assets	-	11,063	18,141	16,237	13,288	10,289	7,034	5,055	4,878	3,194	2,601	1,422	818
Other	-	167	193	92	137	122	195	144	107	88	114	66	18
Allowance for doubtful accounts	-	-1	-1	-	-	-	-	-	-	-	-	-	-22
Current assets	-	11,063	18,141	16,237	13,288	10,289	7,034	5,055	4,878	3,194	2,601	1,422	818
Buildings	-	364	389	406	418	436	581	581	552	493	568	255	255
Accumulated depreciation and impairment	-	-	-	-	-	-	-267	-455	-457	-409	-568	-255	-255
Buildings	-	220	219	210	193	173	313	126	95	84	-	-	-
Machinery and equipment	-	142	139	139	138	137	106	106	105	66	66	4	3
Accumulated depreciation and impairment	-	-	-	-	-	-	-103	-105	-105	-66	-66	-4	-3
Machinery and equipment	-	17	13	10	8	6	3	1	-	-	-	-	-
Tools, furniture and fixtures	-	603	609	607	688	691	867	908	919	776	1,161	964	996
Accumulated depreciation and impairment	-	-	-	-	-	-	-601	-835	-901	-766	-1,161	-964	-996
Tools, furniture and fixtures	-	69	47	34	76	41	266	73	18	11	0	-	-
Property, plant and equipment	-	306	279	254	277	220	582	201	113	95	0	-	-
Guarantee deposits	-	65	65	64	64	64	91	91	90	74	85	89	50
Shares of subsidiaries and associates	-	-	-	-	-	-	-	-	-	-	-	100	-
Investments and other assets	-	66	66	65	73	68	121	102	90	74	85	89	50
Long-term loans receivable from subsidiaries and associates	-	-	-	-	-	-	-	-	-	-	-	2,100	2,180
Guarantee deposits	-	65	65	64	64	64	91	91	90	74	85	89	50
Allowance for doubtful accounts	-	-	-	-	-	-	-	-	-	-	-	-1,832	-2,180
Investments and other assets	-	66	66	65	73	68	121	102	90	74	85	89	50
Guarantee deposits	-	65	65	64	64	64	91	91	90	74	85	89	50
Shares of subsidiaries and associates	-	-	-	-	-	-	-	-	-	-	-	100	-
Investments and other assets	-	66	66	65	73	68	121	102	90	74	85	89	50
Long-term loans receivable from subsidiaries and associates	-	-	-	-	-	-	-	-	-	-	-	2,100	2,180
Guarantee deposits	-	65	65	64	64	64	91	91	90	74	85	89	50
Allowance for doubtful accounts	-	-	-	-	-	-	-	-	-	-	-	-1,832	-2,180
Investments and other assets	-	66	66	65	73	68	121	102	90	74	85	89	50
Non-current assets	-	481	438	372	375	304	987	312	210	174	85	89	50
Non-current assets	-	481	438	372	375	304	987	312	210	174	85	89	50
Assets	-	11,543	18,579	16,608	13,663	10,593	8,022	5,367	5,088	3,368	2,685	1,511	867
Accounts payable - other	-	319	336	194	238	298	279	235	141	171	422	249	139
Contract liabilities	-	-	-	-	-	-	-	-	-	-	22	146	197
Accrued expenses	-	-	-	-	-	-	-	-	-	-	-	7	6
Income taxes payable	-	13	38	43	32	55	5	108	77	3	137	69	2
Deposits received	-	-	-	-	-	-	-	-	-	-	5	100	8
Other	-	47	26	17	17	17	22	24	24	21	24	44	12
Current liabilities	-	1,002	587	338	371	370	306	368	243	195	605	609	360
Long-term accounts payable - other	-	-	-	-	-	-	-	-	-	-	-	-	107
Provision for loss on business of subsidiaries and associates	-	-	-	-	-	-	-	-	-	-	-	-	33
Asset retirement obligations	-	82	83	85	86	107	123	125	113	94	100	47	47
Non-current liabilities	-	184	210	207	177	119	136	129	117	96	100	47	154
Long-term deposits received	-	-	-	-	-	-	-	-	-	-	-	44	44
Non-current liabilities	-	184	210	207	177	119	136	129	117	96	100	47	154
Liabilities	-	1,186	796	545	549	488	442	497	360	291	705	656	514
Share capital	-	3,574	9,083	9,123	9,133	9,135	50	328	1,420	50	789	789	50
Capital surplus	-	6,539	12,048	12,088	12,099	12,100	21,314	21,592	22,684	24,055	24,794	24,794	26,322
Legal capital surplus	-	-	-	-	-	-	-	-	-	-	-	14,210	14,605
Other capital surplus	-	-	-	-	-	-	-	-	-	-	-	10,456	11,589
Capital surplus	-	6,539	12,048	12,088	12,099	12,100	21,314	21,592	22,684	24,055	24,794	24,794	26,322
Retained earnings brought forward	-	-	-	-	-	-	-	-	-	-	-	-24,957	-25,965
Retained earnings	-	-726	-4,403	-5,738	-8,526	-11,528	-14,379	-17,314	-19,553	-21,115	-23,686	-24,805	-26,093
Retained earnings	-	-726	-4,403	-5,738	-8,526	-11,528	-14,379	-17,314	-19,553	-21,115	-23,686	-24,805	-26,093
Treasury shares	-	-	-	-	-	-	-	-	-	-	-	-	-0
Shareholders' equity	-	9,387	16,728	15,474	12,705	9,707	6,985	4,606	4,552	2,990	1,897	778	279
Share acquisition rights	-	885	919	599	418	405	347	275	177	87	84	77	75
Net assets	11,288	10,358	17,783	16,064	13,115	10,104	7,580	4,870	4,728	3,077	1,980	855	354
Liabilities and net assets	-	11,543	18,579	16,608	13,663	10,593	8,022	5,367	5,088	3,368	2,685	1,511	867